Text Size

Cancer Control Following Polypectomy

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Mount Sinai Hospital, New York
Minneapolis Veterans Affairs Medical Center
Medical College of Wisconsin
St. Lukes hospital in Racine, Wiscousin
Massachusetts General Hospital
Cedars-Sinai Medical Center
Valley Presbyterian Hospital
Information provided by (Responsible Party):
Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT00591279
First received: December 26, 2007
Last updated: January 31, 2013
Last verified: January 2013
History of Changes
  Purpose

This study evaluates strategies for the surveillance of post-polypectomy patients for the control of bladder cancer


Condition
Colon Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Cancer Control Following Polypectomy

Resource links provided by NLM:

MedlinePlus related topics: Cancer
U.S. FDA Resources

Further study details as provided by Memorial Sloan-Kettering Cancer Center:

Primary Outcome Measures:
  • evaluate strategies for the surveillance of post-polypectomy patients [ Time Frame: 6 years ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

fecal occult blood


Enrollment: 110
Study Start Date: February 1981
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
A
Barium enema and colonoscopy at one and three years after entry.
B
Barium enema and colonoscopy at three years only after entry.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Patients undergoing colorectal cancer screening

Criteria

Inclusion Criteria:

  • referral for colonoscopy or
  • referral for proctoscopy or for a complete colonoscopy after a proctoscopy or flexible sigmoidoscopy

Exclusion Criteria:

  • prior history of colon cancer, unrelated polypectomy, inflammatory bowel disease, family history of familial polyposis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00591279

Locations
United States, New York
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center
National Cancer Institute (NCI)
Mount Sinai Hospital, New York
Minneapolis Veterans Affairs Medical Center
Medical College of Wisconsin
St. Lukes hospital in Racine, Wiscousin
Massachusetts General Hospital
Cedars-Sinai Medical Center
Valley Presbyterian Hospital
Investigators
Principal Investigator: Sidney Winawer, MD Memorial Sloan-Kettering Cancer Center
  More Information

Additional Information:
Memorial Sloan-Kettering Cancer Center  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT00591279     History of Changes
Other Study ID Numbers: 81-035
Study First Received: December 26, 2007
Last Updated: January 31, 2013
Health Authority: United States: Food and Drug Administration

Keywords provided by Memorial Sloan-Kettering Cancer Center:
large bowel cancer
polyps
colorectal cancer

Additional relevant MeSH terms:
Colonic Neoplasms
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
 Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases

ClinicalTrials.gov processed this record on May 16, 2013